Membranes for dialysis: Can we do without them?

International Journal of Artificial Organs

Volumn 30, Issue 11, 2007, Pages 964-970

  Hoenich, Nicholas A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biocompatibility; Cellulose; Convection; Diffusion; Hemodialysis; Membrane; Renal failure; Solute transport

Indexed keywords

BIOCOMPATIBILITY; BIOLOGY; DIALYSIS; DIALYSIS MEMBRANES; PORE SIZE; SOLUTE TRANSPORT; SYNTHETIC POLYMERS;

'CURRENT; BASIC STRUCTURE; CHRONIC KIDNEY DISEASE; CONVECTION; HAEMODIALYSIS; MATERIAL-BASED; MEMBRANE-BASED; MODIFIED CELLULOSE MEMBRANES; RENAL FAILURE; SYNTHETIC POLYMERS;

CELLULOSE;

ALPHA TOCOPHEROL; CELLULOSE; DIALYSIS FLUID; MACROGOL; POLYMER; POLYSULFONE; PYROXYLIN;

ACUTE KIDNEY FAILURE; ADSORPTION; AMYLOIDOSIS; ARTIFICIAL KIDNEY; ATHEROSCLEROSIS; BIOCOMPATIBILITY; CHRONIC KIDNEY DISEASE; DIAFILTRATION; DIALYSATE; EQUIPMENT DESIGN; HEMODIALYSIS; HOLLOW FIBER; HUMAN; LEUKOPENIA; MATERIALS TESTING; MICROFLUIDICS; NANOFILTER; PARTICULATE MATTER; PROCESS TECHNOLOGY; REVIEW; VASCULAR ACCESS;

EID: 38149010393     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703001104     Document Type: Review

References (38)

1. Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transplant 2000; 15 (Suppl 1): S3-9.
2. Martin RS, Colombi A. Christian Friedrich Schonbein (1799-1868): from the perilous explosive guncotton to the salutary dialysis membranes. Am J Nephrol 1992; 12: 196-8.
3. Thalheimer W. Experimental exchange transfusions for reducing azotemia: use of artificial kidney for this purpose. Proc Soc Exp Biol Med 1937; 37: 641-3.
4. Kolff WJ. The beginning of the artificial kidney. Artif Organs 1993; 17: 293-9.
5. Gotch F, Lipps B, Weaver J Jr, Brandes J, Rosin J, Sargent J, Oja P. Chronic hemodialysis with the hollow fiber artificial kidney (HFAK). Trans Am Soc Artif Intern Organs 1969; 15: 87-96.
6. Ota K, Shimoji T, Salto A, Meda K, Kobayashi K. Bemberg hollow fiber capillary kidney. Trans Am Soc Artif Intern Organs 1973; 19: 98-104.
7. Henderson LW, Ford C, Colton CK, Bluemle LW, Bixler HJ. Uremic blood cleansing by diafiltration using a hollow fiber ultrafilter. Trans Am Soc Artif Intern Organs 1970; 16: 107-12.
8. Funck-Brentano JL, Sausse A, Man NK, Granger A, Rondon-Nucete M, Zingraff J, Jungers P. A new method of hemodialysis combining a high permeability membrane for the medium molecules and a dialysis bath in a closed circuit. Proc Eur Dial Transplant Assoc 1972; 9: 55-66.
9. Hoenich NA, Woffindin C, Stamp S, Roberts SJ, Turnbull J. Synthetically modified cellulose: an alternative to synthetic membranes for use in hemodialysis? Biomaterials 1997; 18: 1299-303.
10. Fushimi F, Nakayama M, Nishimura K, Hiyoshi T. Platelet adhesion contact phase coagulation activation, and C5a generation of polyethylene glycol acid-grafted high flux cellulosic membrane with varieties of grafting amounts. Artif Organs 1998; 22: 821-6.
11. Sirolli V, Di Stante S, Stuard S, Di Liberato L, Amoroso L, Cappelli P, Bonomini M. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis. Int J Artif Organs 2000; 23: 356-64.
12. Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. Int J Artif Organs 2006; 9: 50-60.
13. Triolo L, Malaguti M, Ansali F, Comunian MC, Arcangeloni O, Coppolino F, Marrocco F, Sicoli R, Biagini M. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 185-91.
14. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20: 2587-93.
15. Grassmann A, Gioberge S, Moeller S, Brown G. End-stage Renal Disease - Global Demographics in 2005 and Observed Trends. Int J Artif Organs 2006; 30: 895-97.
16. Farrell PC, Babb AL. Estimation of the permeability of cellulosic membranes from solute dimensions and diffusivities. J Biomed Mater Res 1973; 7: 275-300.
17. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46: 830-7.
18. Ward RA. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 2005; 16: 2421-30.
19. Ronco C, Bowry SK. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. Int J Artif Organs 2001; 24: 726-35.
20. Ofsthun NJ. Limitations of membrane structure and dialyzer design on large solute removal in dialysis. Blood Purif 2000; 18: 264-6.
21. Fissell WH, Humes HD, Fleischman AJ, Roy S. Dialysis and nanotechnology: now, 10 years, or never? Blood Purif 2007; 25: 12-7.
22. Tapia G, Yee J. Biofilm: its relevance in kidney disease. Adv Chronic Kidney Dis 2006; 13: 215-24.
23. Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D. Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif Organs 2004; 28: 210-7.
24. Hayamaa M, Miyasakab T, Mochizukic S, Asaharab H, Yamamotoa K, Kohoria F, Tsujiokab K, Sakai K. Optimum dialysis membrane for endotoxin blocking. J Memb Sci 2003; 219: 15-25.
25. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. JAMA 1968; 203: 1135-7.
26. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977; 59: 879-88.
27. Deppisch R, Gohl H, Smeby L. Microdomain structure of polymeric surfaces - potential for improving blood treatment procedures. Nephrol Dial Transplant 1998; 13: 1354-9.
28. Yoshino M, Kuhlmann MK, Kotanko P, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006; 17: 3510-9.
29. Chauveau P, Nguyen H, Combe C, Chene G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M; French Study Group for Nutrition in Dialysis. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005; 45: 565-71.
30. Rao M, Guo D, Perianayagam MC, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2005; 45: 324-33.
31. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-44.
32. Singh NP, Bansal R, Thakur A, Kohli R, Bansal RC, Agarwal SK. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Ren Fail 2003; 25: 419-30.
33. Domrongkitchaiporn S, Chuncharunee S, Archararit N, Atamasirikul K, Vanichakarn S. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients. J Med Assoc Thai 1997; 80 (Suppl 1): S138-43.
34. Leonard EF, Cortell S, Vitale NG. Membraneless dialysis - is it possible? Contrib Nephrol 2005; 149: 343-53.
35. Bendixen B, Rickwood D. Effects of hydrocyclones on the integrity of animal and microbial cells. Bioseparation 1994; 4: 21-7.
36. Fissell WH, Manley S, Westover A, Humes HD, Fleischman AJ, Roy S. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J 2006; 52: 221-7.
37. Tiranathanagul K, Brodie J, Humes HD. Bioartificial kidney in the treatment of acute renal failure associated with sepsis. Nephrology (Carlton) 2006; 11: 285-91.
38. Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R. The human nephron filter: toward a continuously functioning, implantable artificial nephron system. Blood Purif 2005; 23: 269-74.